Cargando…

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

BACKGROUND: Biomarkers to optimize extended adjuvant endocrine therapy for women with estrogen receptor (ER)–positive breast cancer are limited. The HOXB13/IL17BR (H/I) biomarker predicts recurrence risk in ER-positive, lymph node–negative breast cancer patients. H/I was evaluated in MA.17 trial for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sgroi, Dennis C., Carney, Erin, Zarrella, Elizabeth, Steffel, Lauren, Binns, Shemeica N., Finkelstein, Dianne M., Szymonifka, Jackie, Bhan, Atul K., Shepherd, Lois E., Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Ingle, James N., Porter, Peggy, Muss, Hyman B., Pritchard, Katherine I., Tu, Dongsheng, Rimm, David L., Goss, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888138/ https://www.ncbi.nlm.nih.gov/pubmed/23812955 http://dx.doi.org/10.1093/jnci/djt146

Ejemplares similares

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study
por: Sgroi, Dennis C., et al.
Publicado: (2016)

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
por: Habel, Laurel A, et al.
Publicado: (2013)

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
por: Jerevall, P-L, et al.
Publicado: (2011)

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study
por: Sgroi, Dennis C., et al.
Publicado: (2022)

Letrozole in the extended adjuvant setting: MA.17
por: Goss, Paul E.
Publicado: (2007)

Letrozole in the extended adjuvant setting: MA.17
por: Goss, Paul E.
Publicado: (2008)

Case Report of Subanesthetic Intravenous Ketamine Infusion for the Treatment of Neuropathic Pain and Depression with Suicidal Features in a Pediatric Patient
por: Weber, Garret, et al.
Publicado: (2018)

Gene expression profiling of the tumor microenvironment during breast cancer progression
por: Ma, Xiao-Jun, et al.
Publicado: (2009)

MiR-10 Represses HoxB1a and HoxB3a in Zebrafish
por: Woltering, Joost M., et al.
Publicado: (2008)

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)

Learning from big data: are we undertreating older women with high-risk breast cancer?
por: Sparano, Joseph A, et al.
Publicado: (2016)

The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2007)

The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2008)

Letrozole for Female Infertility
por: Yang, Ai-Min, et al.
Publicado: (2021)

Internet tools to enhance breast cancer care
por: Shachar, Shlomit Strulov, et al.
Publicado: (2016)

Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
por: Liu, Bowen, et al.
Publicado: (2018)

Long noncoding RNA HOXB13‐AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma
por: Xiong, Yu, et al.
Publicado: (2018)

HOXB13 mutations and prostate cancer in Poland
por: Kluźniak, Wojciech, et al.
Publicado: (2012)

Genetic and Clinical Characterization of HOXB2 in Glioma
por: Pan, Xin, et al.
Publicado: (2020)

Differential and Prognostic Significance of HOXB7 in Gliomas
por: Zhou, Xingang, et al.
Publicado: (2021)

The discovery and mechanism of action of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2007)

A decade of letrozole: FACE
por: O’Shaughnessy, Joyce
Publicado: (2007)

An Effect of Letrozole on Gastric Cancer?
por: EL Hadi, Ahmed, et al.
Publicado: (2011)

The discovery and mechanism of action of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2007)

A decade of letrozole: FACE
por: O’Shaughnessy, Joyce
Publicado: (2008)

Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome
por: Hajishafiha, Masomeh, et al.
Publicado: (2013)

Cost-effectiveness analysis of ribociclib plus letrozole versus palbociclib plus letrozole in the United Kingdom
por: Suri, Gaurav, et al.
Publicado: (2019)

Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
por: Lu, Xinli, et al.
Publicado: (2022)

Novel letrozole dosing: is a single dose of letrozole equivalent to traditional 5-day dosing?
por: Martin, Caitlin E.
Publicado: (2020)

Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
por: Darvishi, Ali, et al.
Publicado: (2023)

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy
por: Chavarri-Guerra, Y, et al.
Publicado: (2014)

HOXB5 expression in oral squamous cell carcinoma
por: TUCCI, Renata, et al.
Publicado: (2011)

Corticostriatal circuit defects in Hoxb8 mutant mice
por: Nagarajan, Naveen, et al.
Publicado: (2017)

Experimental and clinicopathological analysis of HOXB9 in gastric cancer
por: Kato, Fumihiko, et al.
Publicado: (2019)

Prostate cancer risk variants of the HOXB genetic locus
por: Dupont, William D., et al.
Publicado: (2021)

Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome [Erratum]
Publicado: (2017)

Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone
por: Kohva, E, et al.
Publicado: (2020)

Retracted: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: An RCT
por: Farzaneh, Farahnaz, et al.
Publicado: (2020)

Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ucf7o5615uqknur1bg6m8k6m3